Flagship Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Flagship Private Wealth's IBB Position: Q2 2026 in Review
Flagship Private Wealth held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,091 shares worth $588K. The position accounts for 0.21% of the portfolio, ranked #68.
Flagship Private Wealth first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Flagship Private Wealth held 3,091 shares of iShares Biotechnology ETF worth $588K as of Q2 2026.
- Flagship Private Wealth left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.21% of Flagship Private Wealth's portfolio in Q2 2026, its #68 holding.
- Flagship Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Flagship Private Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.